Corrigendum to “AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease” [Pharmacol. Res. 18 (2025), 212:107617. doi: 10.1016/j.phrs.2025.107617]

IF 9.1 2区医学 Q1 PHARMACOLOGY & PHARMACY

Pharmacological research Pub Date : 2025-03-22 DOI:10.1016/j.phrs.2025.107689

Lulu Zhang , Yi Zheng , Mingyan Shao , Aiping Chen , Meiyi Liu , Wenlong Sun , Tianxing Li , Yini Fang , Yang Dong , Shipeng Zhao , Hui Luo , Juan Feng , Qi Wang , Lingru Li , Yanfei Zheng

引用次数: 0

查看原文本刊更多论文

“基于alphafold的人工智能对接揭示中药在代谢相关脂肪肝中调节AMPK/SIRT1-TFEB通路”[Pharmacol.]Res. 18(2025), 212:107617。doi: 10.1016 / j.phrs.2025.107617]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacological research 医学-药学

CiteScore

18.70

自引率

3.20%

发文量

491

审稿时长

8 days

期刊介绍： Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. Pharmacological research publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.